Compare CTVA & MET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTVA | MET |
|---|---|---|
| Founded | 1802 | 1863 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Life Insurance |
| Sector | Consumer Staples | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.7B | 50.1B |
| IPO Year | 2018 | N/A |
| Metric | CTVA | MET |
|---|---|---|
| Price | $76.31 | $79.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 12 |
| Target Price | $80.13 | ★ $96.08 |
| AVG Volume (30 Days) | 3.6M | ★ 3.6M |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | 0.93% | ★ 2.91% |
| EPS Growth | ★ 23.08 | N/A |
| EPS | ★ 1.60 | N/A |
| Revenue | ★ $17,401,000,000.00 | N/A |
| Revenue This Year | $6.23 | $1.96 |
| Revenue Next Year | $3.09 | $3.71 |
| P/E Ratio | $48.13 | ★ $16.82 |
| Revenue Growth | ★ 2.92 | N/A |
| 52 Week Low | $53.40 | $65.21 |
| 52 Week High | $77.41 | $87.39 |
| Indicator | CTVA | MET |
|---|---|---|
| Relative Strength Index (RSI) | 64.67 | 51.37 |
| Support Level | $73.87 | $76.14 |
| Resistance Level | $77.11 | $79.68 |
| Average True Range (ATR) | 1.59 | 2.21 |
| MACD | 0.10 | 0.21 |
| Stochastic Oscillator | 85.52 | 50.55 |
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva plans to spin off its seeds business in 2026 and will become a pure-play crop protection company following the divestiture. Corteva operates globally, but around half of revenue comes from North America.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.